A 30-wk, 1.2kg infant develops respiratory distress, grunting and chest retractions within 2 hours of bih. His RR is 70/min. The MOST appropriate next step in management is:
A 30-wk, 1.2kg infant develops respiratory distress, grunting and chest retractions within 2 hours of bih. His RR is 70/min. The MOST appropriate next step in management is:
💡 Explanation
## **Core Concept**
The question revolves around the management of a preterm infant (30 weeks gestation, 1.2 kg) showing signs of respiratory distress syndrome (RDS), likely due to surfactant deficiency. Preterm infants are at high risk for RDS because their lungs are not mature enough to produce sufficient surfactant, leading to increased surface tension within the alveoli, atelectasis, and difficulty in breathing.
## **Why the Correct Answer is Right**
The most appropriate next step in the management of this preterm infant with respiratory distress is to provide **surfactant replacement therapy**. This condition is typical for Respiratory Distress Syndrome (RDS) in preterm infants, caused by surfactant deficiency. Surfactant reduces the surface tension in the lungs, making it easier to expand them during breathing. Administering surfactant can significantly improve lung function, decrease the need for high pressures during mechanical ventilation, and reduce the risk of complications such as pneumothorax and chronic lung disease (bronchopulmonary dysplasia).
## **Why Each Wrong Option is Incorrect**
- **Option A:** While providing oxygen and ensuring a patent airway are crucial, these steps alone do not address the underlying cause of RDS in preterm infants, which is surfactant deficiency.
- **Option B:** Although maintaining adequate ventilation and oxygenation through methods like CPAP (Continuous Positive Airway Pressure) is important and often the first line of treatment for preterm infants with RDS, the infant in question is already showing significant distress (grunting, chest retractions, high respiratory rate), suggesting the need for more direct intervention to correct surfactant deficiency.
- **Option C:** This option might involve treatments that are not directly addressing the immediate need for surfactant replacement.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is the **"Surfactant deficiency"** as a major cause of respiratory distress in preterm infants. Surfactant replacement therapy is a lifesaving intervention for these patients. Early identification and treatment can significantly improve outcomes.